Mereo Biopharma Group PLC
NASDAQ:MREO

Watchlist Manager
Mereo Biopharma Group PLC Logo
Mereo Biopharma Group PLC
NASDAQ:MREO
Watchlist
Price: 4.06 USD 0.25% Market Closed
Market Cap: 620.4m USD
Have any thoughts about
Mereo Biopharma Group PLC?
Write Note

Mereo Biopharma Group PLC
Net Income (Common)

Last Value
3-Years 3-Y CAGR
5-Years 5-Y CAGR
10-Years 10-Y CAGR
Quarterly
Annual
TTM
|

Mereo Biopharma Group PLC
Net Income (Common) Peer Comparison

Comparables:
CNTA
AUTL
BCYC
IMCR
GNS

Competitive Net Income (Common) Analysis
Latest Figures & CAGR of Competitors

Company Net Income (Common) CAGR 3Y CAGR 5Y CAGR 10Y
Mereo Biopharma Group PLC
NASDAQ:MREO
Net Income (Common)
-ÂŁ29.5m
CAGR 3-Years
44%
CAGR 5-Years
2%
CAGR 10-Years
N/A
Centessa Pharmaceuticals PLC
NASDAQ:CNTA
Net Income (Common)
-$151.1m
CAGR 3-Years
-142%
CAGR 5-Years
N/A
CAGR 10-Years
N/A
Autolus Therapeutics PLC
NASDAQ:AUTL
Net Income (Common)
-$208.4m
CAGR 3-Years
-14%
CAGR 5-Years
N/A
CAGR 10-Years
N/A
Bicycle Therapeutics PLC
NASDAQ:BCYC
Net Income (Common)
-$166.3m
CAGR 3-Years
-36%
CAGR 5-Years
-37%
CAGR 10-Years
N/A
Immunocore Holdings PLC
NASDAQ:IMCR
Net Income (Common)
-ÂŁ55.3m
CAGR 3-Years
9%
CAGR 5-Years
5%
CAGR 10-Years
N/A
Genus PLC
LSE:GNS
Net Income (Common)
ÂŁ7.9m
CAGR 3-Years
-45%
CAGR 5-Years
0%
CAGR 10-Years
-12%

See Also

What is Mereo Biopharma Group PLC's Net Income (Common)?
Net Income (Common)
-29.5m GBP

Based on the financial report for Dec 31, 2023, Mereo Biopharma Group PLC's Net Income (Common) amounts to -29.5m GBP.

What is Mereo Biopharma Group PLC's Net Income (Common) growth rate?
Net Income (Common) CAGR 5Y
2%

Over the last year, the Net Income (Common) growth was 14%. The average annual Net Income (Common) growth rates for Mereo Biopharma Group PLC have been 44% over the past three years , 2% over the past five years .

Back to Top